Jadomycin breast cancer cytotoxicity is mediated by a copper-dependent, reactive oxygen species–inducing mechanism

por Hall, Steven R, Blundon, Heather L, Ladda, Matthew A, Robertson, Andrew W, Martinez-Farina, Camilo F, Jakeman, David L, Goralski, Kerry B
Publicado 2015

Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer

por Tomko, Andrea, O’Leary, Lauren, Trask, Hilary, Achenbach, John C., Hall, Steven R., Goralski, Kerry B., Ellis, Lee D., Dupré, Denis J.
Publicado 2019

Physiological constraints dictate toxin spatial heterogeneity in snake venom glands

por Kazandjian, Taline D., Hamilton, Brett R., Robinson, Samuel D., Hall, Steven R., Bartlett, Keirah E., Rowley, Paul, Wilkinson, Mark C., Casewell, Nicholas R., Undheim, Eivind A. B.
Publicado 2022

Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition

por Menzies, Stefanie K., Dawson, Charlotte A., Crittenden, Edouard, Edge, Rebecca J., Hall, Steven R., Alsolaiss, Jaffer, Wilkinson, Mark C., Casewell, Nicholas R., Harrison, Robert A., Ainsworth, Stuart
Publicado 2022

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

por Menzies, Stefanie K., Clare, Rachel H., Xie, Chunfang, Westhorpe, Adam, Hall, Steven R., Edge, Rebecca J., Alsolaiss, Jaffer, Crittenden, Edouard, Marriott, Amy E., Harrison, Robert A., Kool, Jeroen, Casewell, Nicholas R.
Publicado 2022

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms

por Alomran, Nessrin, Blundell, Patricia, Alsolaiss, Jaffer, Crittenden, Edouard, Ainsworth, Stuart, Dawson, Charlotte A., Edge, Rebecca J., Hall, Steven R., Harrison, Robert A., Wilkinson, Mark C., Menzies, Stefanie K., Casewell, Nicholas R.
Publicado 2022

Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing

por Menzies, Stefanie K., Litschka-Koen, Thea, Edge, Rebecca J., Alsolaiss, Jaffer, Crittenden, Edouard, Hall, Steven R., Westhorpe, Adam, Thomas, Brent, Murray, James, Shongwe, Nondusimo, Padidar, Sara, Lalloo, David G., Casewell, Nicholas R., Pons, Jonathan, Harrison, Robert A.
Publicado 2022